ExogenusTherapeutics

[ExogenusTherapeutics @ExogenusT]

@ExogenusT strengthens IP portfolio with patent granted in China and Korea.

TO READ MORE CLICK HERE:
👇 👇 👇 👇 👇
https://t.co/yF71qb5dES

#ExogenusTherapeutics #exosomeresearch #extracellularvesicles #innovativehealthcare #Intellectualproperty #IPChina

[ExogenusTherapeutics @ExogenusT]

We are excited to be one of the 18 startups selected to join the newest edition of the Blue Value Accelerator. At @ExogenusT, we believe that blue resources can become important sources of extracellular vesicles for healthcare.
Meet the startups here:
👉 https://t.co/MoxGw2iQVl

[ExogenusTherapeutics @ExogenusT]

Join our CEO and CSO, Joana Simões Correia at the 4th Exosome Based Therapeutic Development Summit, taking place in Boston, October 4th-6th, to learn more about extracellular vesicles and their translation to the biopharmaceutical market.
https://t.co/Je61aSBkWM

[ExogenusTherapeutics @ExogenusT]

We proud to welcome Tânia Lourenço to our scientific team. Tânia brings a strong background in pre-clinical research and standardized lab practices. Because translating knowledge isn’t all about science, Tânia is currently finishing her MBA...

[ExogenusTherapeutics @ExogenusT]

Our CEO Joana Simões Correia is an invited speaker at the 3rd scientific conference of the Fundação para a Ciência e a Tecnologia (FCT)´s 25th Anniversary Celebration Program.
Fell free to join us today!
https://t.co/8JfCP7Lryc

[ExogenusTherapeutics @ExogenusT]

Great to see our CEO Joana Simões Correia recognized by @Linktoleaders, explaining in her own (Portuguese) words the drive for launching Exogenus Therapeutics and starting this adventurous path that brought us here. https://t.co/rsYz3UspkE

[ExogenusTherapeutics @ExogenusT]

Happy International Women’s Day!
Today we are celebrating gender equality and women’s achievements as part of the workforce. At @ExogenusT, we are proud to be led by a determined female leader and having a team with a strong female presence.

[ExogenusTherapeutics @ExogenusT]

Exogenus Therapeutics announces a new research collaboration with @Boehringer Ingelheim to explore the use of extracellular vesicles as therapeutic tools, focused on pre-clinical testing of its lead candidate Exo-101 in various regenerative medicine indications.

[ExogenusTherapeutics @ExogenusT]

Proud to have our CEO, Joana Simões Correia, participating in the EIC Women Leadership Programme Launching Event #EUeic

[ExogenusTherapeutics @ExogenusT]

Presenting a poster at #ISEV2018 on "Development of a standardized exosome production process for clinical use". Exhibit Hall from 17:15.

[ExogenusTherapeutics @ExogenusT]

Proud to be one of them! https://t.co/0sEwDTQOA3

[Johnson & Johnson Innovation @JNJInnovation]

We saw 8 amazing pitches at #StartupSlam17 where companies get the opportunity to learn and gain support from industry experts to bring their innovation to market. Hear more from the winners that were at this #BIOEurope event with @EBDgroup

[EBD Group @EBDgroup]

🎥 Our very own @EBDKari speaks to Joana Simões Correia of @ExogenusT, winner of the #StartupSlam “best pitch” at #BIOEurope. Watch full interview >> https://t.co/Ik4Bw7jFPa

[ExogenusTherapeutics @ExogenusT]

Not as good as getting the funding ourselves but not bad being mentioned alongside much bigger companies in exosomes! https://t.co/UZnQoaJkCE

[Xconomy @Xconomy]

#VCs Put More Dollars Into Exosomes as Codiak Bio Lands $76M | https://t.co/tiAmHef3Wr

[ExogenusTherapeutics @ExogenusT]

Exogenus also dots the Portuguese Life Sciences map on @Labiotech_eu https://t.co/IKRAoMEWiW

[EIPG @EIPGeu]

What's Going on in the Biotech Ecosystem of Portugal? https://t.co/AuVJn1fu8r via @labiotech_eu

[MEDiSTRAVA, an Inizio Company @MEDiSTRAVA_]

Last startup @ #StartupSlam: Exogenus targets skin lesions. Their platform tech uses exosomes secreted from umbilical cord #BIOEUROPE

[ExogenusTherapeutics @ExogenusT]

And we won! #startups #BioEurope

[ExogenusTherapeutics @ExogenusT]

And Exogenus is among one of the winners today! https://t.co/VX5C2vOETn

[European Innovation Council @EUeic]

The jury is in: @genomebiologics and their drug-disease matching technology take the gold🏆 at the Merck Venture Lounge tonight! Congratulations to the winners and huge thank you to all participants 🎉! #SMEInstrument #SMEIacceleration

[European Innovation Council @EUeic]

What if there was a way for the chronic wounds to heal faster 🤕? Pitching their idea of a tool for the treatment of such wounds, up next is #SMEInstrument innovator @ExogenusT! #SMEIacceleration

[European Innovation Council @EUeic]

Merck Ventures Innovation center opens its doors to #startups and #investors with @merckgroup's Roel Bulthius's keynote on #investment strategies. #SMEInstrument #SMEIacceleration

[ExogenusTherapeutics @ExogenusT]

We're @VentureLounge in Darmstadt today! Double portuguese representation alongside @swordhealth. Best of luck to all!